These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11554061)

  • 21. Correlation between Pathological Findings and the Usefulness of Clinical Guidelines for the Treatment of ANCA-Positive RPGN: A Retrospective Analysis.
    Yamada T; Kashiwagi T; Shimizu A; Tsuruoka S
    J Nippon Med Sch; 2018; 85(5):259-264. PubMed ID: 30464142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of prognostic factors for myeloperoxidase anti-neutrophil cytoplasmic antibody- (MPO-ANCA) associated glomerulonephritis.
    Okano K; Yumura W; Nitta K; Honda K; Uchida K; Nihei H
    Clin Nephrol; 2001 Apr; 55(4):275-81. PubMed ID: 11334312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous occurrence of diabetic glomerulosclerosis, IgA nephropathy, crescentic glomerulonephritis, and myeloperoxidase-antineutrophil cytoplasmic antibody seropositivity in a Chinese patient.
    Lui SL; Chan KW; Yip PS; Chan TM; Lai KN; Lo WK
    Am J Kidney Dis; 2002 Oct; 40(4):E14. PubMed ID: 12324935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous immunoglobulin (IVIg) therapy in MPO-ANCA related polyangiitis with rapidly progressive glomerulonephritis in Japan.
    Muso E; Ito-Ihara T; Ono T; Imai E; Yamagata K; Akamatsu A; Suzuki K
    Jpn J Infect Dis; 2004 Oct; 57(5):S17-8. PubMed ID: 15507757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapidly progressive glomerulonephritis.
    Erwig LP; Rees AJ
    J Nephrol; 1999; 12 Suppl 2():S111-9. PubMed ID: 10688410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Rapidly progressive glomerulonephritis in a solitary kidney positive for anti-glomerular basement membrane antibodies and antineutrophil cytoplasmic antibodies].
    Rychlík I; Tesar V; Zabka J; Zima T; Stejskalová A; Lachmanová J
    Cas Lek Cesk; 1994 May; 133(10):311-4. PubMed ID: 8004656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathological study of myeloperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
    Yorioka N; Taniguchi Y; Amimoto D; Ogata S; Sakikubo E; Yamakido M; Naito T; Shimamoto F
    Clin Nephrol; 1999 Nov; 52(5):293-6. PubMed ID: 10584992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical outcome of patients with coexistent antineutrophil cytoplasmic antibodies and antibodies against glomerular basement membrane.
    Lindic J; Vizjak A; Ferluga D; Kovac D; Ales A; Kveder R; Ponikvar R; Bren A
    Ther Apher Dial; 2009 Aug; 13(4):278-81. PubMed ID: 19695059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Early diagnosis of rapidly progressive glomerulonephritis].
    Maggiore U; Michelassi S; Farsi A; Maggiore Q
    Ann Ital Med Int; 1995; 10(4):227-32. PubMed ID: 8718657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Case of MPO-ANCA positive interstitial pneumonitis and necrotizing, crescentic glomerulonephritis].
    Chikaraishi A; Ohosone Y; Kameda H; Nakamura K; Ogasawara T; Hirakata M; Konishi K; Kuramochi S; Mimori T; Ikeda Y
    Ryumachi; 1996 Dec; 36(6):869-73. PubMed ID: 9122827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies.
    Choi HK; Liu S; Merkel PA; Colditz GA; Niles JL
    J Rheumatol; 2001 Jul; 28(7):1584-90. PubMed ID: 11469466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case with rheumatoid arthritis complicated with ANCA-associated vasculitis].
    Amano K; Nakabayashi K; Tsuzaka K; Takeuchi T; Koide J; Abe T; Matsumura O
    Ryumachi; 1998 Oct; 38(5):741-6. PubMed ID: 9852752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age-dependent survival in rapidly progressive glomerulonephritis: A nationwide questionnaire survey from children to the elderly.
    Takahashi-Kobayashi M; Usui J; Kaneko S; Sugiyama H; Nitta K; Wada T; Muso E; Arimura Y; Makino H; Matsuo S; Yamagata K
    PLoS One; 2020; 15(7):e0236017. PubMed ID: 32658915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antineutrophil cytoplasmic autoantibody-associated rapidly progressive glomerulonephritis in children].
    Deng HY; Gao Y; Li YJ; Zhong F
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):25-7. PubMed ID: 18289465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of methylprednisolone and cyclophosphamide pulse therapy on renal infiltrating cells in patients with crescentic glomerulonephritis.
    Tang Z; Zhou H; Yao X; Hu W; Leishi L
    Chin Med J (Engl); 1997 Mar; 110(3):206-9. PubMed ID: 9594342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapidly progressive glomerulonephritis.
    Bolton WK
    Semin Nephrol; 1996 Nov; 16(6):517-26. PubMed ID: 9125796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Crescentic glomerulonephritis].
    Ueno M; Arakawa M
    Nihon Rinsho; 1994 Aug; 52(8):2082-8. PubMed ID: 7933590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.
    Rutgers A; Slot M; van Paassen P; van Breda Vriesman P; Heeringa P; Tervaert JW
    Am J Kidney Dis; 2005 Aug; 46(2):253-62. PubMed ID: 16112043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Rapidly progressive glomerulonephritis].
    Yamagata K; Koyama A
    Nihon Rinsho; 2004 May; 62 Suppl 5():412-6. PubMed ID: 15197955
    [No Abstract]   [Full Text] [Related]  

  • 40. Differences between myeloperoxidase-specific and -nonspecific P-ANCA-associated renal disease.
    Ohtani H; Wakui H; Komatsuda A; Chyzh KA; Hatakeyama T; Masai R; Okuyama S; Togashi M; Sawada K
    Ren Fail; 2007; 29(2):183-7. PubMed ID: 17365934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.